This report contains market size and forecasts of Varicella Live Vaccine in global, including the following market information:
Global Varicella Live Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Varicella Live Vaccine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Varicella Live Vaccine companies in 2021 (%)
The global Varicella Live Vaccine market was valued at 2438.8 million in 2021 and is projected to reach US$ 3012.2 million by 2028, at a CAGR of 3.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Monovalent Vaccines Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Varicella Live Vaccine include Astellas Pharma Inc., CSL Limited, Emergent BioSolutions, Inc., GlaxoSmithKline plc, Johnson & Johnson, MedImmune, LLC, Merck & Co., Inc., Pfizer, Inc. and Sanofi Pasteur, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Varicella Live Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Varicella Live Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Varicella Live Vaccine Market Segment Percentages, by Type, 2021 (%)
Monovalent Vaccines
Multivalent Vaccines
Global Varicella Live Vaccine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Varicella Live Vaccine Market Segment Percentages, by Application, 2021 (%)
Chicken Pox Immunization
Herpes Zoster Immunization
Measles Immunization
Others
Global Varicella Live Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Varicella Live Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Varicella Live Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Varicella Live Vaccine revenues share in global market, 2021 (%)
Key companies Varicella Live Vaccine sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Varicella Live Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Astellas Pharma Inc.
CSL Limited
Emergent BioSolutions, Inc.
GlaxoSmithKline plc
Johnson & Johnson
MedImmune, LLC
Merck & Co., Inc.
Pfizer, Inc.
Sanofi Pasteur
Serum Institute of India Pvt. Ltd.
Bavarian Nordic
Mitsubishi Tanabe Pharma Corporation
Daiichi Sankyo
Biological E
Panacea Biotec